Urra, XabierAriño, HelenaLlull, LauraAmaro, SergioObach, VíctorCervera Álvarez, ÁlvaroChamorro Sánchez, Ángel2020-01-292020-01-292013-03-191932-6203https://hdl.handle.net/2445/148918Introduction: In up to one third of patients with mild stroke suitable to receive systemic thrombolysis the treatment is not administered because the treating physicians estimate a good spontaneous recovery. However, it is not settled whether the fate of these patients is equivalent to those who are thrombolysed. Methods: We analyzed 203 consecutive patients (134 men and 69 women, mean age 69614 years) without premorbid disability and a NIHSS score #5 at admission [median 3 (IQR 2-4)]. Intravenous thrombolysis was administered within 4.5 hours from stroke onset (n = 119), or it was withheld (n = 84) whenever the treating physician predicted a spontaneous recovery. The baseline risk factors, clinical course, infarction volume, bleeding complications, and functional outcome at 3 months were analyzed and declared to a Web-based registry which was accessible to the local Health Authorities. Results: Expectedly, not thrombolysed patients had the mildest strokes at admission [median 2 (IQR 1-3.75)]. At day 2 to 5, the infarct volume on DWI-MRI was similar in both groups. There were no symptomatic cerebral bleedings in the study. An ordinal regression model adjusted for baseline stroke severity showed that thrombolysis was associated with a greater proportion of patients who shifted down on the modified Rankin Scale score at 3 months (OR 2.66; 95% CI 1.49-4.74, p = 0.001). Conclusions: Intravenous thrombolysis seems to be safe in patients with mild stroke and may be associated with improved outcome compared with untreated patients. These results sup5 p.application/pdfspacc-by (c) Urra, Xabier et al., 2013http://creativecommons.org/licenses/by/3.0/esIsquèmia cerebralMalalties cerebrovascularsHemorràgiaCerebral ischemiaCerebrovascular diseaseHemorrhageinfo:eu-repo/semantics/article6906282020-01-29info:eu-repo/semantics/openAccess23527192